MITF调节IDH1,NNT和一个转录程序,保护黑色素瘤免受活性氧物种的影响
Elisabeth Roider1,2,3, Alexandra I T Lakatos4,5,6, Alicia M McConnell7
1Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. Elisabeth.Roider@usb.ch.
Scientific reports
|September 14, 2024
概括
微相关转录因子 (MITF) 调节细胞的抗氧化剂程序,通过保护抗反应性氧物种 (ROS) 损伤,增强黑色素瘤细胞的存活率. 这一发现突显了MITF在黑色素瘤氧化还原稳定中的作用.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 微相关转录因子 (MITF) 对于黑色素细胞的发育和功能至关重要.
- MITF放大与黑色素瘤的发展和治疗耐药性有关.
- MITF在细胞氧化还原平衡中的作用及其对黑色素瘤存活率的直接影响仍然不完全理解.
研究的目的:
- 研究MITF在调节黑色素瘤细胞抗氧化剂程序中的作用.
- 为了确定MITF介导的抗氧化防御是否有助于黑色素瘤细胞存活,并防止反应性氧物种 (ROS).
- 确定参与这种抗氧化剂计划的MITF基因及其作用机制.
主要方法:
- 在人类黑色素瘤细胞系和患者样本中分析MITF表达及其与氧化还原程序的相关性.
- 使用斑马鱼黑色素瘤模型来评估MITF在减轻ROS介导的DNA损伤方面的体内功能.
- 使用功能实验和基因表达分析来识别和验证MITF目标基因 (例如,IDH1,NNT) 和它们在ROS减少中的作用.
主要成果:
- 发现MITF调节了一个全球抗氧化剂程序,通过保护ROS诱导的损伤,提高黑色素瘤细胞系的存活率.
- 这种MITF驱动的氧化还原程序与黑色素瘤细胞系和患者样本中的MITF表达水平呈正相关性.
- 使用斑马鱼模型的体内研究表明,MITF有效地减少了ROS介导的DNA损伤.
- 特定的MITF标基因,包括IDH1和NNT,被确定为由MITF结合增强元件直接调节,并有助于减少细胞和线粒体ROS.
结论:
- 在黑色素瘤中,MITF是细胞抗氧化状态的重要调节者.
- MITF控制氧化还原平衡的能力有助于黑色素瘤细胞存活,并可能影响治疗结果.
- 准MITF或其下游抗氧化途径可能代表黑色素瘤治疗的新治疗策略.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:46Electron Transport Chain: Complex I and II
12.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
01:06Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K